| Bioactivity | Jun11165 is a SARS-CoV-2 PLpro inhibitor (IC50 ≤ 0.6 μM), which inhibits SARS-CoV-2 with an EC50 value of ≤ 6 μM. Jun11165 can be used in the research of viral infections[1]. |
| Target | IC50: ≤ 0.6 μM (SARS-CoV-2 PLpro)EC50: ≤ 6 μM (SARS-CoV-2). |
| Name | Jun11165 |
| Formula | C22H24N2O2S |
| Molar Mass | 380.50 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Jadhav P, et al. Structure-based design of SARS-CoV-2 papain-like protease inhibitors. Eur J Med Chem. 2023 Dec 5;264:116011. |